Trial intelligence / Profile preview

Pharmacokinetics and Effectiveness of Local Levobupivacaine Injection in Total Joint Replacement

NCT03258697Completed

Sponsor
Chang Gung Memorial Hospital
Start
Oct 2017
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of levobupivacaine in osteoarthritis (OA) (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Dosage of analgesic opioid agent. Started Oct 2017; status: completed.

02

Drugs

levobupivacaine
03

Conditions

osteoarthritis (OA)

Beyond the preview

Go deeper on NCT03258697.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03258697.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call